NAD+ 1000 mg 1000 mg (lyophilized) For research use only (RUO)
Multiply that by 12 months and you are looking at $15,600 to $18,000 annually
The qualification for medication was pretty much what I expected I had to share my personal details (height, weight, goals, etc.) and they approved me for medication
For weight management, be aware that in the UK, GLP-1 medications like Wegovy (semaglutide) and Saxenda (liraglutide) are typically only available through specialist weight management services (tier 3 or 4), with specific BMI thresholds and time-limited treatment courses as per NICE guidance
This research was funded by Breakthrough T1D
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and weight management, and exposure to elevated temperatures during shipping may compromise its therapeutic properties